| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,038 | 14,679 | 14,583 | 14,836 | | Cost of Revenue | 2,712 | 2,806 | 2,768 | 3,109 | | | Gross Profit |
-
| 11,873 | 11,815 | 11,727 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,999 | 11,672 | 9,445 | 9,583 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,500 | 8,110 | 7,890 | 3,102 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (7,909) | (5,520) | (958) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,827 | (7,909) | (5,520) | (958) | | Interest Expense | 514 | 526 | 543 | 597 | | Income Before Tax | 1,313 | (8,435) | (6,063) | (1,555) | | Income Tax Expense | 629 | (4,346) | (2,956) | (2,409) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 684 | (4,089) | (3,107) | 854 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 684 | (4,089) | (3,107) | 854 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $684 | ($4,089) | ($3,107) | $854 |
|
0.26% Nasdaq 
0.04 (1.90%) 
Income Statement
